Rathke cleft cysts are benign, epithelium-lined cystic lesions that occur in the sellar or suprasellar region of the brain. They are remnants of Rathke’s pouch, a normal embryologic structure involved in the development of the anterior pituitary gland. Although often asymptomatic, Rathke cleft cysts can sometimes cause symptoms due to compression of nearby structures, including headaches, visual disturbances, and hormonal imbalances. Radiology plays a crucial role in the diagnosis and management of these cysts, providing detailed imaging that helps differentiate them from other sellar and parasellar lesions, guiding treatment decisions, and monitoring progression or recurrence.
Embryology and Pathophysiology
Rathke cleft cysts originate from residual tissue of Rathke’s pouch, which normally regresses during fetal development. In some cases, epithelial remnants persist and form cysts that can accumulate fluid over time. These cysts are typically lined with a single layer of cuboidal or columnar epithelium, and the cystic fluid may contain protein, mucoid material, or cholesterol crystals. While most Rathke cleft cysts remain small and asymptomatic, cysts that enlarge can compress the pituitary gland or optic apparatus, leading to clinical manifestations.
Common Locations
- Sella turcica – the primary site within the pituitary fossa.
- Suprasellar region – above the pituitary gland, sometimes extending toward the third ventricle.
- Intrasellar and suprasellar – lesions that involve both areas, which may present with a combination of symptoms.
Clinical Presentation
The majority of Rathke cleft cysts are incidental findings on imaging performed for unrelated reasons. However, symptomatic cysts can present with a variety of clinical features depending on their size and location. Compression of the optic chiasm can cause visual disturbances such as bitemporal hemianopia, while pressure on the pituitary gland may lead to hormonal dysfunction, including hypopituitarism or hyperprolactinemia. Headaches are another common symptom, often due to the mass effect of the cyst.
Typical Symptoms
- Visual field defects, particularly bitemporal hemianopia.
- Headaches that may be mild to severe.
- Endocrine disturbances such as fatigue, menstrual irregularities, or growth hormone deficiency.
- Rarely, symptoms of hydrocephalus if the cyst extends into the third ventricle.
Role of Radiology in Diagnosis
Radiology is essential in the identification, characterization, and monitoring of Rathke cleft cysts. Imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) provide detailed information on the size, location, and composition of the cyst. MRI is particularly valuable due to its superior soft tissue contrast, which allows for differentiation between cysts and other sellar or suprasellar lesions like craniopharyngiomas, pituitary adenomas, or arachnoid cysts.
MRI Characteristics
MRI is the preferred imaging modality for Rathke cleft cysts because it can provide high-resolution images of the sellar region. The radiologic appearance of these cysts varies depending on the cyst contents
- T1-weighted imaging – cysts may appear hypo- to hyperintense depending on protein content.
- T2-weighted imaging – typically hyperintense, reflecting fluid content.
- Post-contrast imaging – generally no enhancement of the cyst wall, although mild peripheral enhancement may be present.
CT Scan Findings
CT scans are less sensitive than MRI for soft tissue characterization but can be useful in evaluating bony involvement of the sella turcica or calcifications within the cyst. Rathke cleft cysts usually appear as well-circumscribed, non-calcified, hypodense lesions on CT, with smooth borders and no evidence of aggressive features.
Differential Diagnosis
Radiology helps differentiate Rathke cleft cysts from other sellar and suprasellar lesions. Common differential diagnoses include
- Pituitary adenoma – usually enhances with contrast and may be solid rather than cystic.
- Craniopharyngioma – often shows calcifications and heterogeneous enhancement.
- Arachnoid cyst – typically follows cerebrospinal fluid intensity on all sequences.
- Meningioma – solid lesion with homogeneous enhancement and potential dural tail.
Management and Treatment Considerations
The management of Rathke cleft cysts depends on symptomatology and cyst size. Asymptomatic cysts discovered incidentally are usually monitored with periodic MRI to assess for changes in size or appearance. Symptomatic cysts, especially those causing visual disturbances or significant endocrine dysfunction, may require surgical intervention. The transsphenoidal approach is commonly used for cyst drainage or partial resection, minimizing complications while preserving pituitary function.
Follow-Up and Monitoring
- Regular MRI scans to monitor cyst size and prevent complications.
- Endocrine evaluation to detect and manage pituitary hormone deficiencies.
- Ophthalmologic assessment for patients with visual symptoms.
- Long-term monitoring post-surgery for recurrence or residual cysts.
Prognosis
Rathke cleft cysts generally have a favorable prognosis, particularly when diagnosed early and managed appropriately. Surgical intervention is effective in relieving symptoms and preventing further complications. Recurrence is possible but uncommon, and many patients experience significant improvement in headaches and visual disturbances after treatment. Long-term monitoring ensures that any changes are detected promptly and managed appropriately.
Rathke cleft cysts are benign lesions originating from embryologic remnants of Rathke’s pouch. While often asymptomatic, they can occasionally cause headaches, visual disturbances, or hormonal imbalances. Radiology, particularly MRI, plays a crucial role in diagnosis, characterization, and differentiation from other sellar and suprasellar lesions. Appropriate management, including monitoring or surgical intervention when necessary, ensures optimal outcomes for patients. Understanding the radiologic features and clinical implications of Rathke cleft cysts allows healthcare providers to make informed decisions, improving patient care and long-term prognosis.